Details of the Drug Reposition

General Information of This Drug (ID: DMBL7FH)

Drug Name
RTX-240   DMBL7FH
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1/2 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04372706) RTX-240 Monotherapy. U.S. National Institutes of Health.